Patient no. |
Sex |
Age |
Treatment months |
Max.i.v.dose ng·kg·min−1 |
Haemodynamics beforei.v.iloprost# |
NYHA class |
6‐min walk m |
Outcome |
|
|
|
p.i. |
i.v. |
RA |
PAP |
CI |
PVR |
Sv,O2 |
p.i. |
i.v. |
p.i. |
i.v. |
|
1 |
F |
33 |
4 |
3 |
2.2 |
23 |
64 |
0.9 |
2897 |
45 |
4 |
4 |
0 |
0# |
Dead |
2 |
F |
35 |
23 |
16 |
1.8 |
9 |
71 |
1.6 |
2066 |
57 |
3 |
4 |
250 |
180# |
Dead |
3 |
M |
63 |
17 |
7 |
1.6 |
14 |
59 |
1.6 |
1680 |
54 |
4 |
4 |
0 |
0# |
Dead |
4 |
F |
34 |
9 |
3 |
2.3 |
7 |
78 |
1.6 |
1875 |
60 |
4 |
4 |
150 |
100# |
Dead |
5 |
F |
26 |
19 |
3 |
2.5 |
9 |
66 |
1.6 |
1933 |
49 |
3 |
4 |
350 |
200# |
Dead |
6 |
F |
36 |
3 |
14 |
1.7 |
12 |
54 |
1.6 |
1469 |
46 |
3 |
3 |
280 |
200# |
LT |
7 |
F |
46 |
33 |
11 |
1.5 |
18 |
61 |
1.8 |
1537 |
48 |
4 |
3 |
268 |
388 |
Alive |
8 |
F |
66 |
23 |
10 |
1.8 |
8 |
52 |
1.3 |
1893 |
49 |
4 |
3 |
202 |
331 |
Alive |
9 |
F |
63 |
7 |
10 |
2.2 |
24 |
57 |
1.5 |
1537 |
53 |
4 |
3 |
192 |
387 |
Alive |
10 |
F |
34 |
12 |
3 |
1.5 |
9 |
61 |
1.3 |
1918 |
53 |
4 |
3 |
295 |
330# |
LT |
11 |
F |
50 |
5 |
3 |
1.8 |
11 |
50 |
2.0 |
1074 |
40 |
4 |
3 |
225 |
337# |
LT |
12 |
F |
30 |
3 |
11 |
2.4 |
9 |
74 |
1.4 |
2131 |
52 |
4 |
3 |
264 |
367 |
Alive |
13 |
F |
42 |
17 |
7 |
3.2 |
6 |
58 |
1.5 |
1732 |
52 |
4 |
3 |
145 |
297 |
Alive |
14 |
F |
61 |
27 |
9 |
1.6 |
9 |
69 |
1.6 |
1474 |
56 |
4 |
4 |
0 |
0 |
Alive |
15 |
F |
61 |
1 |
9 |
1.8 |
5 |
41 |
1.5 |
1299 |
56 |
4 |
3 |
243 |
316 |
Alive |
16 |
F |
39 |
1 |
7 |
2.1 |
16 |
65 |
1.7 |
1366 |
60 |
4 |
3 |
0 |
198 |
Alive |
Mean |
|
45 |
13 |
8 |
2.0 |
12 |
61 |
1.6 |
1742 |
52 |
|
|
179 |
227 |
|
sd |
|
14 |
10 |
4 |
0.4 |
6 |
9 |
0.2 |
425 |
6 |
|
|
118 |
140 |
|